MSE-T

N/A

Report date: 2022/10/12 14:48:41

Base Information

Drug NameMSE-T
Drug Alias NameMSE-T
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiosyngen Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiosyngen Pte Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A